NCT02865070

Brief Summary

This is a pilot study is to test a wireless, skin-sensor device against current technology in the NICU to monitor vitals

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 12, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2019

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2021

Completed
Last Updated

June 14, 2022

Status Verified

June 1, 2022

Enrollment Period

3.5 years

First QC Date

August 9, 2016

Last Update Submit

June 12, 2022

Conditions

Keywords

prematurewireless vitalsvitals monitor

Outcome Measures

Primary Outcomes (1)

  • Correlation of vital parameters against current technology

    15 min, 3 hours, 24 hours, 1 week

Secondary Outcomes (1)

  • Adverse events from wireless monitoring sensor assessed through Neonatal Skin Condition Score (NSCS)-sub-study only

    24 hours, 1 week

Study Arms (9)

2 infants (ages 1-6mo) non-NICU setting

Device: Skin Sensor

10 babies (full term, ages 37-42 weeks)

Device: Skin Sensor

5 babies (premature, ages 34-37 weeks)

Device: Skin Sensor

5 babies (premature, ages 31-34 weeks)

Device: Skin Sensor

5 babies (premature, ages 28-31 weeks)

Device: Skin Sensor

5 babies (premature, ages 25-28 weeks)

Device: Skin Sensor

5 babies (premature, ages 23-25 weeks)

Device: Skin Sensor

30 babies (any gestational age under 6 months)

Device: Skin Sensor

25 neonates (ages 24-29 weeks for sub-study)

Device: Skin Sensor

Interventions

Wireless vitals monitor

10 babies (full term, ages 37-42 weeks)2 infants (ages 1-6mo) non-NICU setting25 neonates (ages 24-29 weeks for sub-study)30 babies (any gestational age under 6 months)5 babies (premature, ages 23-25 weeks)5 babies (premature, ages 25-28 weeks)5 babies (premature, ages 28-31 weeks)5 babies (premature, ages 31-34 weeks)5 babies (premature, ages 34-37 weeks)

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Up to 110 premature babies in the Lurie Children's Hospital and Prentice Women's Hospital NICU within 1 week of birth that fall into one of the listed cohorts, fit inclusion and exclusion criteria

You may qualify if:

  • Neonates in different age cohorts from ages 25 weeks gestational age to fullterm infants or infants up to 6 months of age, selected with assistance of NICU staff
  • Currently in NICU and requiring monitoring for heart rate, ECG, respiratory rate, temperature, and pulse oximetry
  • Parents able to understand and provide informed consent for study
  • Infants enrolled in the Pre-Vent study (sub-study only)

You may not qualify if:

  • Over 6 months of age
  • Hemodynamic or other instability precluding testing of new monitoring with concurrent standards
  • Infants at imminent risk of death and neonates with a skin abnormality that precludes assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lurie Children's Hospital

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Amy Paller, MD

    Northwestern University, Lurie Children's Hospital Department of Dermatology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor in Dermatology and Pediatrics

Study Record Dates

First Submitted

August 9, 2016

First Posted

August 12, 2016

Study Start

March 1, 2016

Primary Completion

August 31, 2019

Study Completion

November 10, 2021

Last Updated

June 14, 2022

Record last verified: 2022-06

Locations